%0 Journal Article
%T Systematic review of clinical practice guidelines to identify recommendations for sleep in type 2 diabetes mellitus management.
%A Smyth A
%A Jenkins M
%A Dunham M
%A Kutzer Y
%A Taheri S
%A Whitehead L
%J Diabetes Res Clin Pract
%V 170
%N 0
%D Dec 2020
%M 33157114
%F 8.18
%R 10.1016/j.diabres.2020.108532
%X <B>BACKGROUND: </B>Sleep quality, quantity and timing have been shown to impact glycaemic control, with a role in insulin sensitivity, glucose tolerance and HbA1C levels, in both diabetic and non-diabetic populations. The aim of this study was to identify recommendations for sleep assessment and management in international clinical practice guidelines focused on type 2 diabetes mellitus management in adults.<BR><B>METHODS: </B>Systematic Review.<BR><B>METHODS: </B>Clinical practice guidelines which focused on the management of type 2 diabetes mellitus in adults were included (n = 35). Two independent reviewers utilised the Appraisal of Guidelines for Research and Evaluation tool (AGREE) II and a third reviewer resolved any disagreements. Included guidelines were assessed for recommendations about sleep in diabetes management (n = 14). Data were extracted on sleep recommendations ,themes were generated from the extracted data and narrative syntheses were created.<BR><B>RESULTS: </B>From 1114 identified papers, 35 guidelines met the inclusion criteria. Fourteen of these guidelines included recommendations pertaining to sleep, which broadly fell into five categories; sleep assessment, sleep as a therapeutic target, sleep and co-morbidities of type 2 diabetes mellitus, shift work and sleep and driving. Recommendations varied across guidelines.<BR><B>CONCLUSIONS: </B>Few guidelines provided recommendations relating to assessment and management of sleep in type 2 diabetes care. Most of the recommendations were related to obstructive sleep apnoea. However, few guidelines discussed sleep as a therapeutic intervention for diabetes mellitus or described the potential importance of sleep quality and duration in glycaemic control. Prospero registration number: CRD42020142136.